Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (3): 219-221.DOI: 10.3969/j.issn.1673-8640.2018.03.008
• Orginal Article • Previous Articles Next Articles
Received:
2017-01-06
Online:
2018-03-20
Published:
2018-04-19
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2018.03.008
BC-5800警示标志 | 例数 | 手工镜检 | 阳性 符合率(%) | |
---|---|---|---|---|
阳性(例) | 阴性(例) | |||
白细胞散点图异常 | 2 | 0 | 2 | 0.00 |
未成熟细胞 | 226 | 65 | 161 | 28.76 |
核左移 | 2 | 0 | 2 | 0.00 |
白细胞散点图异常、未成熟细胞 | 37 | 20 | 17 | 54.05 |
未成熟细胞、核左移 | 60 | 36 | 24 | 60.00 |
未成熟细胞、异常/异型淋巴细胞 | 19 | 14 | 5 | 73.68 |
白细胞散点图异常、未成熟细胞、核左移 | 18 | 13 | 5 | 72.22 |
白细胞散点图异常、未成熟细胞、异常/异型淋巴细胞 | 20 | 17 | 3 | 85.00 |
白细胞散点图异常、未成熟细胞、核左移、异常/异型淋巴细胞 | 5 | 5 | 0 | 100.00 |
BC-5800警示标志 | 例数 | 手工镜检 | 阳性 符合率(%) | |
---|---|---|---|---|
阳性(例) | 阴性(例) | |||
白细胞散点图异常 | 2 | 0 | 2 | 0.00 |
未成熟细胞 | 226 | 65 | 161 | 28.76 |
核左移 | 2 | 0 | 2 | 0.00 |
白细胞散点图异常、未成熟细胞 | 37 | 20 | 17 | 54.05 |
未成熟细胞、核左移 | 60 | 36 | 24 | 60.00 |
未成熟细胞、异常/异型淋巴细胞 | 19 | 14 | 5 | 73.68 |
白细胞散点图异常、未成熟细胞、核左移 | 18 | 13 | 5 | 72.22 |
白细胞散点图异常、未成熟细胞、异常/异型淋巴细胞 | 20 | 17 | 3 | 85.00 |
白细胞散点图异常、未成熟细胞、核左移、异常/异型淋巴细胞 | 5 | 5 | 0 | 100.00 |
BC-5800参数 | 敏感性 | 1-特异性 | BC-5800参数 | 敏感性 | 1-特异性 |
---|---|---|---|---|---|
ALY#(×109/L) | ALY%(%) | ||||
0.005 | 0.971 | 0.537 | 0.010 | 0.913 | 0.682 |
0.015 | 0.884 | 0.343 | 0.065 | 0.913 | 0.674 |
0.025 | 0.768 | 0.248 | 0.105 | 0.899 | 0.436 |
0.035 | 0.739 | 0.200 | 0.195 | 0.899 | 0.431 |
0.045 | 0.725 | 0.153 | 0.230 | 0.855 | 0.319 |
0.055 | 0.725 | 0.133 | 0.315 | 0.826 | 0.228 |
0.065 | 0.652 | 0.118 | 0.385 | 0.826 | 0.225 |
0.075 | 0.623 | 0.101 | 0.450 | 0.797 | 0.176 |
LIC#(×109/L) | LIC%(%) | ||||
0.005 | 0.099 | 0.729 | 0.050 | 0.971 | 0.905 |
0.015 | 0.942 | 0.567 | 0.150 | 0.899 | 0.710 |
0.035 | 0.899 | 0.449 | 0.250 | 0.899 | 0.586 |
0.045 | 0.855 | 0.401 | 0.450 | 0.855 | 0.426 |
0.055 | 0.783 | 0.359 | 0.650 | 0.855 | 0.356 |
0.075 | 0.725 | 0.308 | 0.850 | 0.841 | 0.311 |
0.095 | 0.667 | 0.223 | 0.950 | 0.826 | 0.283 |
BC-5800参数 | 敏感性 | 1-特异性 | BC-5800参数 | 敏感性 | 1-特异性 |
---|---|---|---|---|---|
ALY#(×109/L) | ALY%(%) | ||||
0.005 | 0.971 | 0.537 | 0.010 | 0.913 | 0.682 |
0.015 | 0.884 | 0.343 | 0.065 | 0.913 | 0.674 |
0.025 | 0.768 | 0.248 | 0.105 | 0.899 | 0.436 |
0.035 | 0.739 | 0.200 | 0.195 | 0.899 | 0.431 |
0.045 | 0.725 | 0.153 | 0.230 | 0.855 | 0.319 |
0.055 | 0.725 | 0.133 | 0.315 | 0.826 | 0.228 |
0.065 | 0.652 | 0.118 | 0.385 | 0.826 | 0.225 |
0.075 | 0.623 | 0.101 | 0.450 | 0.797 | 0.176 |
LIC#(×109/L) | LIC%(%) | ||||
0.005 | 0.099 | 0.729 | 0.050 | 0.971 | 0.905 |
0.015 | 0.942 | 0.567 | 0.150 | 0.899 | 0.710 |
0.035 | 0.899 | 0.449 | 0.250 | 0.899 | 0.586 |
0.045 | 0.855 | 0.401 | 0.450 | 0.855 | 0.426 |
0.055 | 0.783 | 0.359 | 0.650 | 0.855 | 0.356 |
0.075 | 0.725 | 0.308 | 0.850 | 0.841 | 0.311 |
0.095 | 0.667 | 0.223 | 0.950 | 0.826 | 0.283 |
1 | 尚红,王毓三,申子瑜. 全国临床检验操作规程[M]. 4版. 北京:人民卫生出版社,2015:18. |
2 | 2.Clinical and Laboratory Standards Institute. Reference leukocyte (WBC) differential count (proportional) and evaluation of instrumental methods[S]. H20-A2,CLSI,2007. |
3 | 张蕾,汪嘉,李智,等. XE-2100血液分析仪异常细胞警示标志的实际应用[J]. 检验医学,2010,25(11):837-840. |
[1] | DENG Chenxia, MEI Yanping, ZHANG Xia, HUANG Baoshan, TIAN Dan, CAO Mengting, HU Yongqi, LIN Yongping, TIAN Lijun. Depolymerization effect of optical platelet count on reversible platelet aggregation after blood collection [J]. Laboratory Medicine, 2023, 38(11): 1087-1090. |
[2] | LU Tingyan, GU Danfeng, WANG Yahong, GE Yafang, YANG Haiou. Evaluation of vaginal secretion routine determination modes and review criteria analysis [J]. Laboratory Medicine, 2023, 38(11): 1091-1097. |
[3] | . [J]. Laboratory Medicine, 2023, 38(11): 1098-1100. |
[4] | . [J]. Laboratory Medicine, 2023, 38(10): 983-986. |
[5] | . [J]. Laboratory Medicine, 2023, 38(9): 901-904. |
[6] | . [J]. Laboratory Medicine, 2023, 38(9): 905-908. |
[7] | CHENG Xu, YANG Cunqing, PANG Bo, GU Chun, HOU Xueyun, FEI Jiaxin, WU Min, LI Jun, LIU Guijian. Number and activity of peripheral blood eosinophils in obese people [J]. Laboratory Medicine, 2023, 38(9): 855-859. |
[8] | LEI Jing, MAN Qiuhong, ZHAO Renjia, ZHANG Tiejun, JIANG Yanfeng, XU Kelin, SUO Chen, CHEN Xingdong. Elevated red blood cell distribution width increasing the risk of heart failure:a cohort study based on the UK Biobank [J]. Laboratory Medicine, 2023, 38(9): 860-864. |
[9] | DUAN Lili, JIANG Chang, ZHOU Dongmei. Role of PLR in ankylosing spondylitis patients with positive antinuclear antibody [J]. Laboratory Medicine, 2023, 38(7): 669-674. |
[10] | XIA Yanyan, XIA Yongquan, SONG Guanghao, XIA Mao. Role of coagulation-related monitoring indicators in the course of rivaroxaban anticoagulation for acute venous thromboembolism in elderly patients [J]. Laboratory Medicine, 2023, 38(5): 475-478. |
[11] | CHEN Yi, WANG Jia, XU Zhiwei, ZHAI Yaping, XUAN Weixia. Effects of different anticoagulants on phagocytosis,activation and apoptosis of in vitro neutrophil function [J]. Laboratory Medicine, 2023, 38(5): 479-483. |
[12] | YANG Liyuan, DAI Wanqin, WANG Xiaotong, LOU Xiaoli, WANG Yue, HOU Yanqiang. Effect of peripheral blood neutrophils on interferon-gamma release assay of Mycobacterium tuberculosis [J]. Laboratory Medicine, 2023, 38(5): 484-488. |
[13] | . [J]. Laboratory Medicine, 2023, 38(5): 502-504. |
[14] | . [J]. Laboratory Medicine, 2023, 38(1): 69-72. |
[15] | XIE Yuan, YI Wanwan, SHI Qiuyuan, LÜ Zhongwei, LIU Jin. Clinical value of thromboelastography and conventional coagulation tests in evaluating coagulation status of colon cancer and colon polyps [J]. Laboratory Medicine, 2022, 37(11): 1007-1011. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||